Form 8-K - Current report:
SEC Accession No. 0001193125-25-005649
Filing Date
2025-01-14
Accepted
2025-01-14 07:01:05
Documents
58
Period of Report
2025-01-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d903812d8k.htm   iXBRL 8-K 25285
2 EX-99.1 d903812dex991.htm EX-99.1 47405
6 GRAPHIC g903812ex99_1p10g1.jpg GRAPHIC 358206
7 GRAPHIC g903812ex99_1p11g1.jpg GRAPHIC 352298
8 GRAPHIC g903812ex99_1p12g1.jpg GRAPHIC 200541
9 GRAPHIC g903812ex99_1p13g1.jpg GRAPHIC 350708
10 GRAPHIC g903812ex99_1p14g1.jpg GRAPHIC 335847
11 GRAPHIC g903812ex99_1p15g1.jpg GRAPHIC 300317
12 GRAPHIC g903812ex99_1p16g1.jpg GRAPHIC 295834
13 GRAPHIC g903812ex99_1p17g1.jpg GRAPHIC 218698
14 GRAPHIC g903812ex99_1p18g1.jpg GRAPHIC 287859
15 GRAPHIC g903812ex99_1p19g1.jpg GRAPHIC 297293
16 GRAPHIC g903812ex99_1p1g1.jpg GRAPHIC 365671
17 GRAPHIC g903812ex99_1p20g1.jpg GRAPHIC 269143
18 GRAPHIC g903812ex99_1p21g1.jpg GRAPHIC 252531
19 GRAPHIC g903812ex99_1p22g1.jpg GRAPHIC 215076
20 GRAPHIC g903812ex99_1p23g1.jpg GRAPHIC 204761
21 GRAPHIC g903812ex99_1p24g1.jpg GRAPHIC 393036
22 GRAPHIC g903812ex99_1p25g1.jpg GRAPHIC 383726
23 GRAPHIC g903812ex99_1p26g1.jpg GRAPHIC 221178
24 GRAPHIC g903812ex99_1p27g1.jpg GRAPHIC 230432
25 GRAPHIC g903812ex99_1p28g1.jpg GRAPHIC 234950
26 GRAPHIC g903812ex99_1p29g1.jpg GRAPHIC 163275
27 GRAPHIC g903812ex99_1p2g1.jpg GRAPHIC 634475
28 GRAPHIC g903812ex99_1p30g1.jpg GRAPHIC 287772
29 GRAPHIC g903812ex99_1p31g1.jpg GRAPHIC 255894
30 GRAPHIC g903812ex99_1p32g1.jpg GRAPHIC 394550
31 GRAPHIC g903812ex99_1p33g1.jpg GRAPHIC 251468
32 GRAPHIC g903812ex99_1p34g1.jpg GRAPHIC 347009
33 GRAPHIC g903812ex99_1p35g1.jpg GRAPHIC 368678
34 GRAPHIC g903812ex99_1p36g1.jpg GRAPHIC 227595
35 GRAPHIC g903812ex99_1p37g1.jpg GRAPHIC 255833
36 GRAPHIC g903812ex99_1p38g1.jpg GRAPHIC 263651
37 GRAPHIC g903812ex99_1p39g1.jpg GRAPHIC 351157
38 GRAPHIC g903812ex99_1p3g1.jpg GRAPHIC 305270
39 GRAPHIC g903812ex99_1p40g1.jpg GRAPHIC 235803
40 GRAPHIC g903812ex99_1p41g1.jpg GRAPHIC 83192
41 GRAPHIC g903812ex99_1p42g1.jpg GRAPHIC 248221
42 GRAPHIC g903812ex99_1p43g1.jpg GRAPHIC 295683
43 GRAPHIC g903812ex99_1p44g1.jpg GRAPHIC 359679
44 GRAPHIC g903812ex99_1p4g1.jpg GRAPHIC 266775
45 GRAPHIC g903812ex99_1p5g1.jpg GRAPHIC 304638
46 GRAPHIC g903812ex99_1p6g1.jpg GRAPHIC 358900
47 GRAPHIC g903812ex99_1p7g1.jpg GRAPHIC 352922
48 GRAPHIC g903812ex99_1p8g1.jpg GRAPHIC 289271
49 GRAPHIC g903812ex99_1p9g1.jpg GRAPHIC 290006
  Complete submission text file 0001193125-25-005649.txt   18068027

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA urgn-20250114.xsd EX-101.SCH 2848
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20250114_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20250114_pre.xml EX-101.PRE 11260
60 EXTRACTED XBRL INSTANCE DOCUMENT d903812d8k_htm.xml XML 3643
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38079 | Film No.: 25527736
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)